Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6849)	1/28/1999 4:03:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

PFIZER SALES DIVISION SCORES NO. 1 WITH DOCTORS Business Wire January 28, 1999, 1:34 p.m. ET Business Editors/Medical & Pharmaceutical Writers Pharmaceutical Sales Forces Most Valued by Physicians 1. Pfizer 2. SmithKline Beecham 3. Merck 4. Wyeth-Ayerst 5. Glaxo Wellcome 6. SmithKline & French 7. Glaxo 8. Bristol-Myers Squibb 9. Parke-Davis 10. Eli Lilly Source: Scott-Levin, Sales Force Structures & Strategies 1998 NEWTON, Pa.--(BW HealthWire)--Jan. 28, 1999--The Pfizer pharmaceutical sales division placed No. 1 overall in a 1998 Scott-Levin survey of U.S. physicians across nine core specialty groups: general/family practitioners, internists, cardiologists, obstetricians/gynecologists, pediatricians, general surgeons, orthopedic surgeons, gastroenterologists, and psychiatrists. This marks the fourth consecutive year a Pfizer sales force has finished first across these groups. Pfizer also was rated first by U.S. physicians in four of these key specialty groups: general/family practitioners, cardiologists, general surgeons, and psychiatrists. In addition to the unprecedented attention paid to the erectile dysfunction treatment Viagra, Pfizer also benefited from the addition of a fifth, 650-rep primary care force, Alta; the success of the cholesterol reducer Lipitor, which Pfizer co-promotes with Parke-Davis; and a direct-to-consumer campaign for the Alzheimer's treatment Aricept. These rankings come from Sales Force Structures & Strategies 1998-99, the 11th edition of the longest-running study of pharmaceutical sales forces, conducted annually by the health care consulting firm Scott-Levin. Twenty-eight physician specialty groups were surveyed for this year(1)s study. Other leaders among sales forces were Merck, rated first by internal medicine specialists, nephrologists, and endocrinologists; Glaxo Wellcome, first with pulmonologists and neurologists; Wyeth-Ayerst, tops with OB/GYNs and orthopedic surgeons; Schering, first with allergists and otorhinolaryngologists; Astra Merck, the favorite among gastroenterologists; and Ross, foremost with pediatricians. For more information on the study, contact Bryna Elder at 215/860-0440; fax: 215/860-5477; email@scottlevin.com. Scott-Levin, a division of PMSI/Scott-Levin Inc., provides consulting and communications services to pharmaceutical companies worldwide. You can visit Scott-Levin on the World Wide Web at scottlevin.com. --30--aec/ix* CONTACT: Bryna Elder or Carolyn Gretton, 215/860-0440, 800/982-5613 Fax: 215/860-5477 email@scottlevin.com www.scottlevin.com